Human Papillomavirus (HPV) affordability analysis

MMGH supported the WHO Department of Immunisation and Biologicals (IVB) in defining a logical framework to assess the barriers to access human papillomavirus (HPV) vaccine in middle-income countries, with a focus on affordability. The project, performed in collaboration with the Clinton Health Access Initiative (CHAI), led to the identification of a subset of countries that can benefit from specific technical assistance related to affordability and access.